Sandesh Mahatme
CIK 1511034 · CFO · last filed 2026-06-09
Sandesh Mahatme is a CFO who has filed 49 SEC Form 4 insider transactions across 5 companies since 2012. The most recent filing, for CRSP, was dated Jun 9, 2026. Across all open-market trades the lifetime net is −$50.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $585.1K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$585.1K
5
49
-$50.71M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CRSP | Director | — | $49.80 | — | $0 | 3 | 2026-06-09 |
| VOR | CFO | 0 | $14.36 | $0 | $0 | 2 | 2025-12-09 |
| Spyre Therapeutics, Inc. (AGLE) Delisted | Director | — | $12.01 | — | $0 | 7 | 2022-06-09 |
| SRPT | EVP, CFO & CBO | 30,851 | $15.31 | $472.3K | -$50.71M | 29 | 2020-07-09 |
| FLXN | Director | 4,500 | $25.05 | $112.7K | $0 | 8 | 2020-06-12 |
Recent Filings
49 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-09 | CRSP | Grant (A) | — | $0 | EDGAR |
| 2025-12-09 | VOR | Mixed | −694,137 | $0 | EDGAR |
| 2025-07-10 | VOR | Grant (A) | +13,882,750 | $0 | EDGAR |
| 2025-06-06 | CRSP | Grant (A) | — | $0 | EDGAR |
| 2024-05-31 | CRSP | Grant (A) | — | $0 | EDGAR |
| 2022-06-09 | Spyre Therapeutics, Inc. (AGLE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-09 | Spyre Therapeutics, Inc. (AGLE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-07-09 | SRPT | Mixed | −16,619 | $74.9K | EDGAR |
| 2020-06-12 | FLXN | Grant (A) | +4,500 | $0 | EDGAR |
| 2020-06-10 | Spyre Therapeutics, Inc. (AGLE) Delisted | Grant (A) | — | $0 | EDGAR |